Additionally, we examined the relationship between NOX4 expression and the effectiveness of immunotherapy in HCC using the Easlier package and discovered that the low NOX4 expression group had a greater percentage of immunotherapy response. This evidence concerns the gene NOX4 and hepatocellular carcinoma.